Global Gene Therapy-based Drug Market Size, Status and Forecast 2023-2027

Report ID: 865290 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Viral Gene Delivery System
        1.2.3 Non-viral Gene Delivery System
    1.3 Market by Application
        1.3.1 Global Gene Therapy-based Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Neurological Diseases
        1.3.3 Cancer
        1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gene Therapy-based Drug Market Perspective (2016-2027)
    2.2 Gene Therapy-based Drug Growth Trends by Regions
        2.2.1 Gene Therapy-based Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gene Therapy-based Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Gene Therapy-based Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Gene Therapy-based Drug Industry Dynamic
        2.3.1 Gene Therapy-based Drug Market Trends
        2.3.2 Gene Therapy-based Drug Market Drivers
        2.3.3 Gene Therapy-based Drug Market Challenges
        2.3.4 Gene Therapy-based Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy-based Drug Players by Revenue
        3.1.1 Global Top Gene Therapy-based Drug Players by Revenue (2016-2021)
        3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy-based Drug Revenue
    3.4 Global Gene Therapy-based Drug Market Concentration Ratio
        3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2020
    3.5 Gene Therapy-based Drug Key Players Head office and Area Served
    3.6 Key Players Gene Therapy-based Drug Product Solution and Service
    3.7 Date of Enter into Gene Therapy-based Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy-based Drug Breakdown Data by Type
    4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2016-2021)
    4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2022-2027)

5 Gene Therapy-based Drug Breakdown Data by Application
    5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2016-2021)
    5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gene Therapy-based Drug Market Size (2016-2027)
    6.2 North America Gene Therapy-based Drug Market Size by Type
        6.2.1 North America Gene Therapy-based Drug Market Size by Type (2016-2021)
        6.2.2 North America Gene Therapy-based Drug Market Size by Type (2022-2027)
        6.2.3 North America Gene Therapy-based Drug Market Size by Type (2016-2027)
    6.3 North America Gene Therapy-based Drug Market Size by Application
        6.3.1 North America Gene Therapy-based Drug Market Size by Application (2016-2021)
        6.3.2 North America Gene Therapy-based Drug Market Size by Application (2022-2027)
        6.3.3 North America Gene Therapy-based Drug Market Size by Application (2016-2027)
    6.4 North America Gene Therapy-based Drug Market Size by Country
        6.4.1 North America Gene Therapy-based Drug Market Size by Country (2016-2021)
        6.4.2 North America Gene Therapy-based Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gene Therapy-based Drug Market Size (2016-2027)
    7.2 Europe Gene Therapy-based Drug Market Size by Type
        7.2.1 Europe Gene Therapy-based Drug Market Size by Type (2016-2021)
        7.2.2 Europe Gene Therapy-based Drug Market Size by Type (2022-2027)
        7.2.3 Europe Gene Therapy-based Drug Market Size by Type (2016-2027)
    7.3 Europe Gene Therapy-based Drug Market Size by Application
        7.3.1 Europe Gene Therapy-based Drug Market Size by Application (2016-2021)
        7.3.2 Europe Gene Therapy-based Drug Market Size by Application (2022-2027)
        7.3.3 Europe Gene Therapy-based Drug Market Size by Application (2016-2027)
    7.4 Europe Gene Therapy-based Drug Market Size by Country
        7.4.1 Europe Gene Therapy-based Drug Market Size by Country (2016-2021)
        7.4.2 Europe Gene Therapy-based Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy-based Drug Market Size (2016-2027)
    8.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type
        8.2.1 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application
        8.3.1 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gene Therapy-based Drug Market Size by Region
        8.4.1 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gene Therapy-based Drug Market Size (2016-2027)
    9.2 Latin America Gene Therapy-based Drug Market Size by Type
        9.2.1 Latin America Gene Therapy-based Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Gene Therapy-based Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Gene Therapy-based Drug Market Size by Type (2016-2027)
    9.3 Latin America Gene Therapy-based Drug Market Size by Application
        9.3.1 Latin America Gene Therapy-based Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Gene Therapy-based Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Gene Therapy-based Drug Market Size by Application (2016-2027)
    9.4 Latin America Gene Therapy-based Drug Market Size by Country
        9.4.1 Latin America Gene Therapy-based Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Gene Therapy-based Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy-based Drug Market Size (2016-2027)
    10.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type
        10.2.1 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application
        10.3.1 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gene Therapy-based Drug Market Size by Country
        10.4.1 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Biogen
        11.1.1 Biogen Company Details
        11.1.2 Biogen Business Overview
        11.1.3 Biogen Gene Therapy-based Drug Introduction
        11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.1.5 Biogen Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Gene Therapy-based Drug Introduction
        11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Gilead Sciences
        11.3.1 Gilead Sciences Company Details
        11.3.2 Gilead Sciences Business Overview
        11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction
        11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.3.5 Gilead Sciences Recent Development
    11.4 Sarepta Therapeutics
        11.4.1 Sarepta Therapeutics Company Details
        11.4.2 Sarepta Therapeutics Business Overview
        11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction
        11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.4.5 Sarepta Therapeutics Recent Development
    11.5 Alnylam Pharmaceuticals
        11.5.1 Alnylam Pharmaceuticals Company Details
        11.5.2 Alnylam Pharmaceuticals Business Overview
        11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction
        11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.5.5 Alnylam Pharmaceuticals Recent Development
    11.6 Amgen
        11.6.1 Amgen Company Details
        11.6.2 Amgen Business Overview
        11.6.3 Amgen Gene Therapy-based Drug Introduction
        11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.6.5 Amgen Recent Development
    11.7 Spark Therapeutics
        11.7.1 Spark Therapeutics Company Details
        11.7.2 Spark Therapeutics Business Overview
        11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction
        11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.7.5 Spark Therapeutics Recent Development
    11.8 Akcea Therapeutics
        11.8.1 Akcea Therapeutics Company Details
        11.8.2 Akcea Therapeutics Business Overview
        11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction
        11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.8.5 Akcea Therapeutics Recent Development
    11.9 bluebird bio
        11.9.1 bluebird bio Company Details
        11.9.2 bluebird bio Business Overview
        11.9.3 bluebird bio Gene Therapy-based Drug Introduction
        11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.9.5 bluebird bio Recent Development
    11.10 Sunway Biotech
        11.10.1 Sunway Biotech Company Details
        11.10.2 Sunway Biotech Business Overview
        11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction
        11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.10.5 Sunway Biotech Recent Development
    11.11 SIBIONO
        11.11.1 SIBIONO Company Details
        11.11.2 SIBIONO Business Overview
        11.11.3 SIBIONO Gene Therapy-based Drug Introduction
        11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.11.5 SIBIONO Recent Development
    11.12 AnGes
        11.12.1 AnGes Company Details
        11.12.2 AnGes Business Overview
        11.12.3 AnGes Gene Therapy-based Drug Introduction
        11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.12.5 AnGes Recent Development
    11.13 Orchard Therapeutics
        11.13.1 Orchard Therapeutics Company Details
        11.13.2 Orchard Therapeutics Business Overview
        11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction
        11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.13.5 Orchard Therapeutics Recent Development
    11.14 Human Stem Cells Institute
        11.14.1 Human Stem Cells Institute Company Details
        11.14.2 Human Stem Cells Institute Business Overview
        11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction
        11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2016-2021)
        11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Viral Gene Delivery System
    Table 3. Key Players of Non-viral Gene Delivery System
    Table 4. Global Gene Therapy-based Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Gene Therapy-based Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gene Therapy-based Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Gene Therapy-based Drug Market Share by Regions (2016-2021)
    Table 8. Global Gene Therapy-based Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Gene Therapy-based Drug Market Share by Regions (2022-2027)
    Table 10. Gene Therapy-based Drug Market Trends
    Table 11. Gene Therapy-based Drug Market Drivers
    Table 12. Gene Therapy-based Drug Market Challenges
    Table 13. Gene Therapy-based Drug Market Restraints
    Table 14. Global Gene Therapy-based Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Gene Therapy-based Drug Market Share by Players (2016-2021)
    Table 16. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy-based Drug as of 2020)
    Table 17. Ranking of Global Top Gene Therapy-based Drug Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Gene Therapy-based Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Therapy-based Drug Product Solution and Service
    Table 21. Date of Enter into Gene Therapy-based Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Gene Therapy-based Drug Revenue Market Share by Type (2016-2021)
    Table 25. Global Gene Therapy-based Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Gene Therapy-based Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Gene Therapy-based Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Gene Therapy-based Drug Revenue Market Share by Application (2016-2021)
    Table 29. Global Gene Therapy-based Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Gene Therapy-based Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Biogen Company Details
    Table 62. Biogen Business Overview
    Table 63. Biogen Gene Therapy-based Drug Product
    Table 64. Biogen Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 65. Biogen Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Gene Therapy-based Drug Product
    Table 69. Novartis Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Gilead Sciences Company Details
    Table 72. Gilead Sciences Business Overview
    Table 73. Gilead Sciences Gene Therapy-based Drug Product
    Table 74. Gilead Sciences Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 75. Gilead Sciences Recent Development
    Table 76. Sarepta Therapeutics Company Details
    Table 77. Sarepta Therapeutics Business Overview
    Table 78. Sarepta Therapeutics Gene Therapy-based Drug Product
    Table 79. Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 80. Sarepta Therapeutics Recent Development
    Table 81. Alnylam Pharmaceuticals Company Details
    Table 82. Alnylam Pharmaceuticals Business Overview
    Table 83. Alnylam Pharmaceuticals Gene Therapy-based Drug Product
    Table 84. Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 85. Alnylam Pharmaceuticals Recent Development
    Table 86. Amgen Company Details
    Table 87. Amgen Business Overview
    Table 88. Amgen Gene Therapy-based Drug Product
    Table 89. Amgen Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 90. Amgen Recent Development
    Table 91. Spark Therapeutics Company Details
    Table 92. Spark Therapeutics Business Overview
    Table 93. Spark Therapeutics Gene Therapy-based Drug Product
    Table 94. Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 95. Spark Therapeutics Recent Development
    Table 96. Akcea Therapeutics Company Details
    Table 97. Akcea Therapeutics Business Overview
    Table 98. Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 99. Akcea Therapeutics Recent Development
    Table 100. bluebird bio Company Details
    Table 101. bluebird bio Business Overview
    Table 102. bluebird bio Gene Therapy-based Drug Product
    Table 103. bluebird bio Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 104. bluebird bio Recent Development
    Table 105. Sunway Biotech Company Details
    Table 106. Sunway Biotech Business Overview
    Table 107. Sunway Biotech Gene Therapy-based Drug Product
    Table 108. Sunway Biotech Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 109. Sunway Biotech Recent Development
    Table 110. SIBIONO Company Details
    Table 111. SIBIONO Business Overview
    Table 112. SIBIONO Gene Therapy-based Drug Product
    Table 113. SIBIONO Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 114. SIBIONO Recent Development
    Table 115. AnGes Company Details
    Table 116. AnGes Business Overview
    Table 117. AnGes Gene Therapy-based Drug Product
    Table 118. AnGes Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 119. AnGes Recent Development
    Table 120. Orchard Therapeutics Company Details
    Table 121. Orchard Therapeutics Business Overview
    Table 122. Orchard Therapeutics Gene Therapy-based Drug Product
    Table 123. Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 124. Orchard Therapeutics Recent Development
    Table 125. Human Stem Cells Institute Company Details
    Table 126. Human Stem Cells Institute Business Overview
    Table 127. Human Stem Cells Institute Gene Therapy-based Drug Product
    Table 128. Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million)
    Table 129. Human Stem Cells Institute Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy-based Drug Market Share by Type: 2020 VS 2027
    Figure 2. Viral Gene Delivery System Features
    Figure 3. Non-viral Gene Delivery System Features
    Figure 4. Global Gene Therapy-based Drug Market Share by Application: 2020 VS 2027
    Figure 5. Neurological Diseases Case Studies
    Figure 6. Cancer Case Studies
    Figure 7. Other Case Studies
    Figure 8. Gene Therapy-based Drug Report Years Considered
    Figure 9. Global Gene Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Gene Therapy-based Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Gene Therapy-based Drug Market Share by Regions: 2020 VS 2027
    Figure 12. Global Gene Therapy-based Drug Market Share by Regions (2022-2027)
    Figure 13. Global Gene Therapy-based Drug Market Share by Players in 2020
    Figure 14. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy-based Drug as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2020
    Figure 16. Global Gene Therapy-based Drug Revenue Market Share by Type (2016-2021)
    Figure 17. Global Gene Therapy-based Drug Revenue Market Share by Type (2022-2027)
    Figure 18. North America Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Gene Therapy-based Drug Market Share by Type (2016-2027)
    Figure 20. North America Gene Therapy-based Drug Market Share by Application (2016-2027)
    Figure 21. North America Gene Therapy-based Drug Market Share by Country (2016-2027)
    Figure 22. United States Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Gene Therapy-based Drug Market Share by Type (2016-2027)
    Figure 26. Europe Gene Therapy-based Drug Market Share by Application (2016-2027)
    Figure 27. Europe Gene Therapy-based Drug Market Share by Country (2016-2027)
    Figure 28. Germany Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Gene Therapy-based Drug Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Gene Therapy-based Drug Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Gene Therapy-based Drug Market Share by Region (2016-2027)
    Figure 38. China Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Gene Therapy-based Drug Market Share by Type (2016-2027)
    Figure 46. Latin America Gene Therapy-based Drug Market Share by Application (2016-2027)
    Figure 47. Latin America Gene Therapy-based Drug Market Share by Country (2016-2027)
    Figure 48. Mexico Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Gene Therapy-based Drug Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Gene Therapy-based Drug Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Gene Therapy-based Drug Market Share by Country (2016-2027)
    Figure 54. Turkey Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Biogen Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 58. Novartis Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 59. Gilead Sciences Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 60. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 62. Amgen Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 63. Spark Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 64. Akcea Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 65. bluebird bio Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 66. Sunway Biotech Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 67. SIBIONO Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 68. AnGes Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 69. Orchard Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 70. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Frequently Asked Questions
Gene Therapy-based Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Therapy-based Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Therapy-based Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports